Drugs / COVID-19 Vaccine Janssen
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05048940 | Sep 2021 | COVID-19 | Marqués de Valdecilla Research Institute (IDIVAL) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 Vaccine Janssen | “COVID-19 Vaccine Janssen, injectable suspension” NCT05048940 ↗ |
| Modality | Vaccine | “COVID-19 Vaccine Janssen, injectable suspension” NCT05048940 ↗ |
| Route | Intramuscular | “0.5 ml millilitre(s) Intramuscular use” NCT05048940 ↗ |